Researchers used machine learning models to assess the physical and primarily mental performance of superagers.
Ipsen and Biomunex enter agreement for BMX-502
BMX-502 is designed to engage and activate mucosal-associated invariant T cells to target and destroy malignant cells. Credit: Pickadook/Shutterstock. Ipsen has entered an exclusive worldwide